Literature DB >> 11008949

Comparison of conformal radiation therapy techniques within the dynamic radiotherapy project 'Dynarad'.

P Mavroidis1, B K Lind, J Van Dijk, K Koedooder, W De Neve, C De Wagter, B Planskoy, J C Rosenwald, B Proimos, C Kappas, D Claudia, M Benassi, G Chierego, A Brahme.   

Abstract

The objective of the dynamic radiotherapy project 'Dynarad' within the European Community has been to compare and grade treatment techniques that are currently applied or being developed at the participating institutions. Cervical cancer was selected as the tumour site on the grounds that the involved organs at risk, mainly the rectum and the bladder, are very close to the tumour and partly located inside the internal target volume. In this work, a solid phantom simulating the pelvic anatomy was used by institutions in Belgium, France, Greece, Holland, Italy, Sweden and the United Kingdom. The results were evaluated using both biological and physical criteria. The main purpose of this parallel evaluation is to test the value of biological and physical evaluations in comparing treatment techniques. It is demonstrated that the biological objective functions allow a much higher conformality and a more clinically relevant scoring of the outcome. Often external beam treatment techniques have to be combined with intracavitary therapy to give clinically acceptable results. However, recent developments can reduce or even eliminate this need by delivering more conformal dose distributions using intensity modulated external dose delivery. In these cases the reliability of the patient set-up procedure becomes critical for the effectiveness of the treatment.

Entities:  

Mesh:

Year:  2000        PMID: 11008949     DOI: 10.1088/0031-9155/45/9/302

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

1.  A graphic user interface toolkit for specification, report and comparison of dose-response relations and treatment plans using the biologically effective uniform dose.

Authors:  Fan-Chi Su; Panayiotis Mavroidis; Chengyu Shi; Brigida Costa Ferreira; Niko Papanikolaou
Journal:  Comput Methods Programs Biomed       Date:  2010-03-24       Impact factor: 5.428

2.  Tradeoffs for assuming rigid target motion in Mlc-based real time target tracking radiotherapy: a dosimetric and radiobiological analysis.

Authors:  T Roland; C Shi; Y Liu; R Crownover; P Mavroidis; N Papanikolaou
Journal:  Technol Cancer Res Treat       Date:  2010-04

3.  Evaluation on lung cancer patients' adaptive planning of TomoTherapy utilising radiobiological measures and Planned Adaptive module.

Authors:  Fan-Chi Su; Chengyu Shi; Panayiotis Mavroidis; Prema Rassiah-Szegedi; Niko Papanikolaou
Journal:  J Radiother Pract       Date:  2009-01-01

4.  Comparison of the helical tomotherapy against the multileaf collimator-based intensity-modulated radiotherapy and 3D conformal radiation modalities in lung cancer radiotherapy.

Authors:  P Mavroidis; C Shi; G A Plataniotis; M G Delichas; B Costa Ferreira; S Rodriguez; B K Lind; N Papanikolaou
Journal:  Br J Radiol       Date:  2010-09-21       Impact factor: 3.039

5.  Incorporating system latency associated with real-time target tracking radiotherapy in the dose prediction step.

Authors:  Teboh Roland; Panayiotis Mavroidis; Chengyu Shi; Nikos Papanikolaou
Journal:  Phys Med Biol       Date:  2010-04-19       Impact factor: 3.609

6.  Assessing four-dimensional radiotherapy planning and respiratory motion-induced dose difference based on biologically effective uniform dose.

Authors:  F-C Su; C Shi; P Mavroidis; V Goytia; R Crownover; P Rassiah-Szegedi; N Papanikolaou
Journal:  Technol Cancer Res Treat       Date:  2009-06

7.  Consequences of anorectal cancer atlas implementation in the cooperative group setting: radiobiologic analysis of a prospective randomized in silico target delineation study.

Authors:  Panayiotis Mavroidis; Drosoula Giantsoudis; Musaddiq J Awan; Jasper Nijkamp; Coen R N Rasch; Joop C Duppen; Charles R Thomas; Paul Okunieff; William E Jones; Lisa A Kachnic; Niko Papanikolaou; Clifton D Fuller
Journal:  Radiother Oncol       Date:  2014-07-01       Impact factor: 6.280

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.